KEGG   DRUG: Empagliflozin, linagliptin and metformin hydrochloride
Entry
D11856            Mixture   Drug                                   
Name
Empagliflozin, linagliptin and metformin hydrochloride;
Trijardy xr (TN)
Product
Component
Empagliflozin [DR:D10459], Linagliptin [DR:D09566], Metformin hydrochloride [DR:D00944]
Class
Antidiabetic agent
 DG02044  Hypoglycemic agent
  DG03228  Combination of metformin, DPP-4 inhibitor and SGLT2 inhibitor
Remark
ATC code: A10BD27
Product: D11856<US>
Efficacy
Antidiabetic
  Disease
Type 2 diabetes mellitus [DS:H00409]
Interaction
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 A ALIMENTARY TRACT AND METABOLISM
  A10 DRUGS USED IN DIABETES
   A10B BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS
    A10BD Combinations of oral blood glucose lowering drugs
     A10BD27 Metformin, linagliptin and empagliflozin
      D11856  Empagliflozin, linagliptin and metformin hydrochloride <US>
USP drug classification [BR:br08302]
 Blood Glucose Regulators
  Antidiabetic Combinations
   Empagliflozin/ Linagliptin/ Metformin Hydrochloride
    D11856  Empagliflozin, linagliptin and metformin hydrochloride
Drug groups [BR:br08330]
 Antidiabetic agent
  DG02044  Hypoglycemic agent
   DG03228  Combination of metformin, DPP-4 inhibitor and SGLT2 inhibitor
    D11856  Empagliflozin, linagliptin and metformin hydrochloride
Drug classes [BR:br08332]
 Antidiabetic agent
  DG02044  Hypoglycemic agent
   D11856  Empagliflozin, linagliptin and metformin hydrochloride
LinkDB

» Japanese version   » Back

DBGET integrated database retrieval system